CALL/QIAGEN/80.07/0.0999/20.12.24 Share Price

Warrant

DE000GZ6LE12

Real-time BOERSE MUENCHEN 15:26:57 26/06/2024 BST
0.004 EUR -20.00% Intraday chart for CALL/QIAGEN/80.07/0.0999/20.12.24
Current month-54.55%
1 month-64.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
26/06/24 0.004 -20.00%
25/06/24 0.005 0.00%
24/06/24 0.005 -37.50%
21/06/24 0.008 -11.11%
20/06/24 0.009 +12.50%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 03:26 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying QIAGEN N.V.
Issuer Goldman Sachs
WKN GZ6LE1
ISINDE000GZ6LE12
Date issued 04/01/2023
Strike 80.07
Maturity 20/12/2024 (177 Days)
Parity 10.01 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.348
Lowest since issue 0.004
Spread 0.05
Spread %92.59%

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
41.04 USD
Average target price
50.39 USD
Spread / Average Target
+22.78%
Consensus